NCT05082350

Brief Summary

A controlled clinical intervention study is proposed to determine the effect of black garlic consumption on biomarkers of cardiovascular function and associated pathologies in a healthy population at risk for cardiovascular disease. Black garlic is the result of a fermentation process of common white garlic in which the temperature and humidity are kept constant over a long period of time. Black garlic is particularly rich in phenolic compounds such as S-allylcysteine or S-allyl-mercaptocysteine, with antioxidant action. It also provides vitamin C and other valuable antioxidant substances such as flavonoids.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 8, 2021

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

October 18, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2021

Completed
Last Updated

October 18, 2021

Status Verified

October 1, 2021

Enrollment Period

10 months

First QC Date

June 8, 2021

Last Update Submit

October 15, 2021

Conditions

Keywords

black garlicsulphur bioactive compoundshypercholesterolemiahyperlipemiainflammationendothelial dysfunction

Outcome Measures

Primary Outcomes (2)

  • Impact on blood pressure

    Blood pressure (diastolic, systolic)

    changes observed from baseline at day 0 compared to 12 weeks.

  • Impact on lipid profile

    Plasma levels of total cholesterol, HDL, LDL, VLDL (very low-density lipoprotein), triglycerides, apolipoproteins A1 and B.

    changes observed from baseline at day 0 compared to 12 weeks.

Secondary Outcomes (9)

  • Impact on blood cells (Hematology)

    changes observed from baseline at day 0 compared to 12 weeks.

  • evaluation of liver function to determine product safety

    changes observed from baseline at day 0 compared to 12 weeks.

  • Changes in cytokine levels

    changes observed from baseline at day 0 compared to 12 weeks.

  • Changes in chemokine MCP-1 (monocyte chemotactic protein)

    changes observed from baseline at day 0 compared to 12 weeks.

  • Changes in C reactive protein

    changes observed from baseline at day 0 compared to 12 weeks.

  • +4 more secondary outcomes

Study Arms (2)

Healthy Group,

EXPERIMENTAL

Daily consumption of 4 cloves of black garlic, not cooked, during 12 weeks

Dietary Supplement: black garlic

Hypercholesterolemia

EXPERIMENTAL

Daily consumption of 4 cloves of black garlic, not cooked, during 12 weeks

Dietary Supplement: black garlic

Interventions

black garlicDIETARY_SUPPLEMENT

Daily consumption of 4 cloves of black garlic, not cooked, during 12 weeks

Healthy Group,Hypercholesterolemia

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy Group:
  • Total blood cholesterol levels of less than 200 mg/dL
  • LDL-cholesterol levels of less than 135 mg/dL
  • Not suffer from any other pathology.
  • No drugs, hormones or dietary supplements, no smoking, no pregnancy, no vegetarianism, etc.
  • Cardiovascular Risk Group:
  • Total cholesterol levels between 200-300 mg/dL
  • LDL-cholesterol levels between 135-175 mg/dL.
  • No acute or chronic pathology, except hypercholesterolemia
  • No drugs, hormones or dietary supplements, no smoking, no pregnancy, no vegetarianism, etc.).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Católica de Murcia (UCAM)

Murcia, 30107, Spain

Location

MeSH Terms

Conditions

HypercholesterolemiaHypertensionHyperlipidemiasInflammation

Condition Hierarchy (Ancestors)

DyslipidemiasLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesVascular DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: A controlled clinical intervention study is proposed to determine the effect of black garlic consumption on biomarkers of cardiovascular function and associated pathologies in a healthy population at risk for cardiovascular disease.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Vicedean of Pharmacy Degree

Study Record Dates

First Submitted

June 8, 2021

First Posted

October 18, 2021

Study Start

September 1, 2020

Primary Completion

June 30, 2021

Study Completion

November 30, 2021

Last Updated

October 18, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations